US Patent Issued to Abbott Diabetes Care on April 21 for "Interconnect for on-body analyte monitoring device" (California Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,092, issued on April 21, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Interconnect for on-body analyte monitoring device" was invented by Gary A. Stafford (Hayward, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are systems and methods for providing a compressible interconnect for allowing electrical communication between an electronics unit and an analyte sensor in an on-body analyte monitoring device. In other embodiments, systems and methods are provided for reducing the Z-height of an on-body analyte monitoring device by utilizing novel interconnects."

The patent was filed on Jan. 19, 2022, under Applic...